(Q24244189)

English

Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation

scientific article

In more languages

edit

Statements

0 references

1 reference

Europe PubMed Central

title

Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation (English)

0 references

0 references

0 references

0 references

1 reference

K Cahill

1

K

Cahill

1 reference

stated in

PubMed

PubMed publication ID

17636794

retrieved

9 December 2023

M Ussher

series ordinal

2

author given names

M

author last names

Ussher

1 reference

stated in

PubMed

PubMed publication ID

17636794

retrieved

9 December 2023

publication date

1 September 1996

0 references

published in

Cochrane Database of Systematic Reviews

0 references

cites work

Measures of abstinence in clinical trials: issues and recommendations

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD005353.PUB2

retrieved

21 January 2018

Early and late weight gain following smoking cessation in the Lung Health Study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD005353.PUB2

retrieved

21 January 2018

Identifiers

DOI

10.1002/14651858.CD005353.PUB2

0 references

Fatcat ID

release_wcbrkxbcizcgtjwd7mhtihnvne

0 references

PubMed publication ID

17636794

0 references

(Q24244189)

Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)